These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11705525)

  • 21. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 22. Growing up with perinatal HIV infection: time for a HAART to heart.
    Siberry GK; Joyner M; Hutton N
    J Pediatr; 2008 Oct; 153(4):456-7. PubMed ID: 18847617
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic syndrome in HIV-infected patients: no different than the general population?
    Jones CY
    Clin Infect Dis; 2007 Mar; 44(5):735-8. PubMed ID: 17278069
    [No Abstract]   [Full Text] [Related]  

  • 24. Key data from the 11th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV.
    Boehme RE; Cameron S
    Antivir Ther; 2009; 14(8):1195-208. PubMed ID: 20032550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular Disease and HIV Infection.
    Klein D; Hurley LB; Sidney S
    N Engl J Med; 2003 Nov; 349(19):1869-70; author reply 1869-70. PubMed ID: 14602888
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular risks of antiretroviral therapies.
    Mondy K; Tebas P
    Annu Rev Med; 2007; 58():141-55. PubMed ID: 17217329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does antiretroviral-induced hyperlipidaemia constitute a cardiovascular risk?
    Gilleece Y; Nelson M
    J HIV Ther; 2001 May; 6(2):37-9. PubMed ID: 11501202
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity.
    ter Hofstede HJ; Burger DM; Koopmans PP
    Neth J Med; 2003 Dec; 61(12):393-403. PubMed ID: 15025414
    [No Abstract]   [Full Text] [Related]  

  • 29. Care of the HIV-positive patient in the emergency department in the era of highly active antiretroviral therapy.
    Venkat A; Piontkowsky DM; Cooney RR; Srivastava AK; Suares GA; Heidelberger CP
    Ann Emerg Med; 2008 Sep; 52(3):274-85. PubMed ID: 18358567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of cardiovascular disease in HIV-infected patients.
    Das S
    J Antimicrob Chemother; 2010 Mar; 65(3):386-9. PubMed ID: 20026610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.
    Barbaro G; Barbarini G
    Chemotherapy; 2006; 52(4):161-5. PubMed ID: 16675900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients.
    de Castro IF; Micheloud D; Berenguer J; Guzmán-Fulgencio M; Catalán P; Miralles P; Alvarez E; López JC; Cosín J; Lorente R; Muñoz-Fernández MA; Resino S
    AIDS; 2010 Aug; 24(13):2059-67. PubMed ID: 20616694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.
    Mondy KE; Gottdiener J; Overton ET; Henry K; Bush T; Conley L; Hammer J; Carpenter CC; Kojic E; Patel P; Brooks JT;
    Clin Infect Dis; 2011 Feb; 52(3):378-86. PubMed ID: 21217185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wasting and obesity in HIV outpatients.
    Hodgson LM; Ghattas H; Pritchitt H; Schwenk A; Payne L; Macallan DC
    AIDS; 2001 Nov; 15(17):2341-2. PubMed ID: 11698716
    [No Abstract]   [Full Text] [Related]  

  • 36. Giant cell myocarditis associated with multiple autoimmune disorders following highly active antiretroviral therapy for human immunodeficiency virus type 1 infection.
    Ikeda Y; Inomata T; Nishinarita R; Oikawa J; Kishihara J; Koitabashi T; Wada T; Takeuchi I; Ako J
    Int J Cardiol; 2016 Mar; 206():79-81. PubMed ID: 26780680
    [No Abstract]   [Full Text] [Related]  

  • 37. Bone disease and HIV infection.
    Rojo P; Ramos JT
    Clin Infect Dis; 2006 Jul; 43(1):111-2; author reply 113-4. PubMed ID: 16758430
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin Resistance and the cardiometabolic syndrome in HIV infection.
    Bevilacqua M; Dominguez LJ; Barbagallo M
    J Cardiometab Syndr; 2009; 4(1):40-3. PubMed ID: 19245515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic and skeletal complications of HIV infection: the price of success.
    Morse CG; Kovacs JA
    JAMA; 2006 Aug; 296(7):844-54. PubMed ID: 16905789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronological and biological age in HIV infection.
    De Socio GV; Ricci E; Parruti G; Maggi P; Madeddu G; Quirino T; Bonfanti P
    J Infect; 2010 Nov; 61(5):428-30. PubMed ID: 20833202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.